Daewoong Pharmaceutical Co Ltd

069620

Company Profile

  • Business description

    Daewoong Pharmaceutical Co Ltd develops, manufactures and sells prescription drug products. The company's product portfolio comprises products such as Moxicle, Plunazol Cap, Bearcef tab, Newdizime etc. It develops and promotes brands such as Ursa, Nabota, Luphere, Easyef, Cretropin. The company has manufacturing facilities at Hyangnam and Sungnam.

  • Contact

    12, Bongeunsa-ro 114-gil
    Daewoong Pharmaceutical Building
    Gangnam-gu
    Seoul
    KOR

    T: +82 25508800

    https://www.daewoong.co.kr

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,777

Stocks News & Analysis

stocks

Solid start to fiscal 2026 for BHP

Production guidance is maintained by management.
stocks

Coca-Cola earnings: Innovation and brand strength underpin growth

We plan to raise our fair value estimate of Coca-Cola stock.
stocks

Going into earnings, is Netflix stock a buy, a sell, or fairly valued?

Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,314.8017.10-0.18%
CAC 408,258.8652.790.64%
DAX 4024,330.0371.230.29%
Dow JONES (US)46,924.74218.160.47%
FTSE 1009,426.9923.420.25%
HKSE25,697.57329.98-1.27%
NASDAQ22,953.6736.88-0.16%
Nikkei 22549,372.6856.620.11%
NZX 50 Index13,306.4471.41-0.53%
S&P 5006,735.350.220.00%
S&P/ASX 2009,026.3014.00-0.15%
SSE Composite Index3,899.0517.28-0.44%

Market Movers